Biotricity Recognizes Remote Monitoring Is Key to Chronic Care Management

Biotricity Inc., a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, affirms that the rise of chronic disease necessitates a new care management paradigm. The company is developing remote patient monitoring (RPM) solutions that could help ease the healthcare burden while simultaneously improving patient outcomes.
 
According to the Centers for Disease Control and Prevention (CDC), chronic diseases are responsible for 7 of 10 deaths, and account for 86 percent of our nation’s healthcare costs. Today, patients with chronic conditions, such as heart disease and diabetes, are not benefiting from optimal treatment. Chronic conditions are slow to develop and long lasting; unlike acute conditions, direct medical intervention in the form of a hospital stay is only necessary during a health crisis. Hospitals and clinics face tremendous resource shortages, and consequently there is little patient-physician interaction and long gaps between follow-up. With RPM solutions, healthcare providers can ensure that their patients benefit from early intervention by catching vital changes, adjusting treatment plans in real-time, and detecting problems before they become serious.
 
“If healthcare providers implemented RPM technology that could record a patient’s basic metrics and symptoms in real-time over a longer period, they could start building a holistic overview of a patient’s chronic health condition,” said Waqaas Al-Siddiq, Biotricity founder and CEO. “They could also benefit from valuable insights such as the morphology and progression of a chronic disease, which are difficult to realize without proper data.”
 
RPM solutions could further improve patient outcomes by increasing patient adherence through engagement. Such solutions encourage patients to actively manage their own chronic health conditions by offering real-time, precise, clinically relevant data that is easy to understand and that supports lasting behavioral change through ongoing feedback.
 
Biotricity recently announced its support of progressive changes in telemedicine healthcare policy, which points to a shift in healthcare towards remote patient monitoring at the federal and state levels. The U.S. House of Representatives and Senate are currently considering two new bills (MTPA and CONNECT) that look at reducing the restrictions that the Centers for Medicare & Medicaid Services (CMS) currently has on telemedicine coverage. If passed, the two bills will expand the services eligible to be offered via telehealth. CMS recognizes the value of RPM for healthcare and recently released new payment rules that will give mHealth technology a better shot at reimbursement. Biotricity’s RPM device platform aligns with telemedicine and can be integrated with telehealth solutions. Its flagship product, the Bioflux solution, is a remote patient monitoring device that assists in the diagnosis of heart conditions.
 
“Remote patient monitoring solutions that can slip into a physician’s workflow and offer constant relevant data that creates engaged patients will truly improve patient-physician relationships, drive down costs, and realize better health outcomes,” said Al-Siddiq.